RAB3A and Alzheimer disease: identified a series of synaptic biomarkers, such as the presynaptic proteins SNAP47, Rab3A, GAP43, and SYBU, which were altered in cerebrospinal fluid (CSF) and brain samples in patients with PDD, DLB and Alzheimer’s disease (AD) [12, 13].